Company · CIK 1944885
Apollomics Inc.
| CIK | 1944885 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | E9 |
| Business address | CA |
| Listed | APLM (Nasdaq), APLMW (Nasdaq) |
| First annual or quarterly report | 2023-03-31 |
Offerings
5 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-294154 | 2026-03-09 | 2026-06-02 | 2 | |
| 333-279549 | 2024-05-20 | 2024-05-29 | 2 | |
| 333-278430 | 2024-04-01 | 2024-05-24 | 3 | |
| 333-278431 | 2024-04-01 | 2024-04-24 | 2 | |
| 333-272552 | 2023-06-09 | 2023-09-29 | 4 |
Filings
15| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-06-02 | EFFECTDeclared effective | 333-294154 | 9999999995-26-001838 |
| 2026-03-09 | F-3Shelf registered | 333-294154 | 0001193125-26-098822 |
| 2024-05-29 | EFFECTDeclared effective | 333-279549 | 9999999995-24-001678 |
| 2024-05-24 | 424B5Shelf takedown | 333-278430 | 0001193125-24-147149 |
| 2024-05-20 | F-3Shelf registered | 333-279549 | 0001193125-24-142892 |
| 2024-04-24 | EFFECTDeclared effective | 333-278431 | 9999999995-24-001110 |
| 2024-04-24 | EFFECTDeclared effective | 333-278430 | 9999999995-24-001109 |
| 2024-04-01 | F-3Shelf registered | 333-278431 | 0001193125-24-083469 |
| 2024-04-01 | F-3Shelf registered | 333-278430 | 0001193125-24-083452 |
| 2023-09-29 | EFFECTDeclared effective | 333-272552 | 9999999995-23-002856 |
| 2023-07-24 | EFFECTDeclared effective | 333-272552 | 9999999995-23-002176 |
| 2023-07-07 | F-1/AAmendment | 333-272552 | 0001193125-23-183796 |
| 2023-06-09 | F-1Registration filed | 333-272552 | 0001193125-23-164455 |
| 2023-02-28 | EFFECTDeclared effective | 333-268525 | 9999999995-23-000494 |
| 2022-09-29 | DRSDraft made public | 377-06388 | 0000950123-22-009989 |